@lockitt mate, I assume you are talking about me. I've supported this stock ever since I've owned, with only the odd whinge. This is a forum mate - for discussion of all stuff, not just rose glasses. A few things have become very obvious to me in the last two weeks that concern me, hence my decision to sell half my holding. So, if you want facts, here are some:
1) nothing outstanding has yet been discovered as the good doctor has informed in his assessment of the last announcement
2) With the exception of Ross, the other directors have small or no holdings. I own more than most. Additionally, did you see them buying any prior this "material" announcement? That to me is a clear indication of what they think about the risk associated with Chanape
3) We have had CR after CR and the SP has never established an upward trend on the back of any "material" announcements. We now have almost 1 billion shares on the register, that is MASSIVE
4) if we need to dig deeper, guess what - more cash required. Where will that come from? Based on results to date, do you think a major will chip in...? Of course not.
5) Smell of an oily rag - did you look at salaries in the annual report? I wouldn't mind getting paid that to manage my own company.
Like you, I've not sold 1 share since I bought them, until today. I've been loyal as any other LT'er.
I'm not down ramping, hell, I still own half my original holding. Friday will determine if they go as well. I'm not talk like Byron, I SOLD today. It's not a lack of courage to hold mate, it's assessing the position and acting however much that hurts.
I honestly hope for better results, but my mind tells me the odds are stacking up against me.
I'm also happy to cop sh@t if I'm wrong.
- Forums
- ASX - By Stock
- ICG
- Ann: Trading Halt
Ann: Trading Halt, page-26
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ICG (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $5.133M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $5.418K | 1.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2522932 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3149226 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2522932 | 0.005 |
10 | 4430194 | 0.004 |
13 | 19206780 | 0.003 |
4 | 4399980 | 0.002 |
3 | 6199950 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3149226 | 8 |
0.007 | 1447760 | 5 |
0.008 | 950160 | 3 |
0.009 | 1033282 | 3 |
0.011 | 350000 | 1 |
Last trade - 10.32am 13/11/2024 (20 minute delay) ? |
Featured News
ICG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online